Grant Dixon advises a range of international clients on pharmaceutical compliance and enforcement matters. In this area, Grant regularly counsels pharmaceutical manufacturers on U.S. CGMP compliance and remediating deficiencies identified during regulatory inspections, including preparation of submissions to regulators. He also conducts internal investigations of allegations concerning compliance with Current Good Manufacturing Practices, Current Good Clinical Practices, and other U.S. FDA regulatory requirements.

Grant also represents companies that manufacture feed, feed ingredients, drugs, biologics and medical devices for animals, those that provide veterinary medical services and that perform biomedical research, as well as clients in related industries.